Skip to main content
2024 CRT Conference Main banner
Back

Innovation

BRS, DES and DCB Technologies [Non-CME]

BRS, DES and DCB Technologies [Non-CME]

Sunday, March 10, 2024
8:00 AM – 12:15 PM ET

    Program Director(s)

  • Bernardo Cortese, MD, FESC, FSCAI

    consultant Cardiologist
    Fondazione Ricerca e Innovazione Cardiovascolare
    Milano, Lombardia, Italy

  • Aloke Finn, MD

    Medical Director CVPath/Assoc. Prof. Of Medicine University of Maryland
    CVPath
    Gaithersburg, Maryland, United States

  • Bruno Scheller, MD

    Professor of Clinical and Experimental Interventional Cardiology
    University of Saarland
    Homburg, Saarland, Germany

Disclosure(s):
Aloke V. Finn, MD: No relationships to disclose
Bruno Scheller, MD: B.Braun: Clinical Trial Investigator (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); InnoRa GmbH: Major Stockholder (not including mutual funds) (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Presentations:

  • 8:00 AM – 8:08 AM ET
    DCBs: Comparing DCBs: Drug Design Matters – Preclinical

    Speaker: Aloke V. Finn, MD – CVPath

  • 8:00 AM – 9:20 AM ET
    DCB FOR CORONARY APPLICATIONS

    Moderator: Bernardo Cortese, MD, FESC, FSCAI – Fondazione Ricerca e Innovazione Cardiovascolare

    Moderator: Bruno Scheller, MD – University of Saarland

  • 8:08 AM – 8:16 AM ET
    DCBs: Comparing DCBs: Drug Design Matters – Clinical

    Speaker: Bruno Scheller, MD – University of Saarland

  • 8:16 AM – 8:24 AM ET
    Updated Meta-Analysis on PTx Safety in the Periphery

    Speaker: Sahil A. Parikh, MD, FSCAI – Columbia University Vagelos College of Physicians and Surgeons

  • 8:24 AM – 8:32 AM ET
    DCBs for Coronary ISR: Technical Considerations and Concerns

    Speaker: Aloke V. Finn, MD – CVPath

  • 8:32 AM – 8:40 AM ET
    DCB for De Novo Coronary Disease

    Speaker: Bernardo Cortese, MD, FESC, FSCAI – Fondazione Ricerca e Innovazione Cardiovascolare

  • 8:40 AM – 8:48 AM ET
    DCBs Other Indications (CTO, Bifurcations, etc)

    Speaker: Tuomas Rissanen, MD, PhD – North Karelia Central Hospital

  • 8:48 AM – 8:56 AM ET
    How Can We Use DCB in 80% of the De-Novo PCI?

    Speaker: Simon Eccleshall, MD – NNUH NHS

  • 8:56 AM – 9:04 AM ET
    Long-Term BVS Results in ACS and Chronic CAD

    Speaker: Jean-Francois Tanguay, MD – Montreal Heart Institute/ Univeristy of Montreal

  • 9:04 AM – 9:20 AM ET
    Panel Discussion | DCB for Coronary Applications

    Panel Moderator: Bernardo Cortese, MD, FESC, FSCAI – Fondazione Ricerca e Innovazione Cardiovascolare

    Panel Moderator: Bruno Scheller, MD – University of Saarland

    Panel Discussant: Sandeep Basavarajaiah, MD

    Panel Discussant: Antonio Colombo, MD – Humanitas IRCCS

    Panel Discussant: Simon Eccleshall, MD – NNUH NHS

    Panel Discussant: Aloke V. Finn, MD – CVPath

    Panel Discussant: Sahil A. Parikh, MD, FSCAI – Columbia University Vagelos College of Physicians and Surgeons

    Panel Discussant: Jean-Francois Tanguay, MD – Montreal Heart Institute/ Univeristy of Montreal

    Panel Discussant: Ruben Yannick Gerold Tijssen, MD, PhD – St. Antonius Ziekenhuis Nieuwegein / Academic Medical Center Amsterdam

  • 9:20 AM – 9:28 AM ET
    Lessons from the Agent IDE ISR Trial

    Speaker: Robert W. Yeh, MD, MSc – Beth Israel Deaconess Medical Center

  • 9:20 AM – 10:15 AM ET
    PARADE OF DCB PROGRAMS AND TECHNOLOGIES

    Moderator: Ricardo A. Costa, MD, PhD – Institute Dante Pazzanese of Cardiology

    Moderator: Simon Eccleshall, MD – NNUH NHS

    Moderator: Aloke V. Finn, MD – CVPath

  • 9:28 AM – 9:36 AM ET
    MagicTouch Sirolimus DCB: ISR and De Novo

    Speaker: Bernardo Cortese, MD, FESC, FSCAI – Fondazione Ricerca e Innovazione Cardiovascolare

  • 9:36 AM – 9:44 AM ET
    Defining Non-Inferiority for DEB Versus DES: Update SELUTION ISR and De Novo Programs

    Speaker: Donald E. Cutlip, MD, FACC – Beth Israel Deaconess Medical Center

  • 9:44 AM – 9:52 AM ET
    SeQuent Sirolimus DCB: Current Status

    Speaker: Bruno Scheller, MD – University of Saarland

  • 9:52 AM – 10:00 AM ET
    Virtue Sirolimus Angio Infusion Balloon: Status Update

    Speaker: Dean J. Kereiakes, MD, FACC, MSCAI – The Christ Hospital Health Network

  • 10:00 AM – 10:15 AM ET
    Panel Discussion | Parade of DCB Programs and Technologies

    Moderator: Aloke V. Finn, MD – CVPath

    Moderator: Bernardo Cortese, MD, FESC, FSCAI – Fondazione Ricerca e Innovazione Cardiovascolare

    Moderator: Bruno Scheller, MD – University of Saarland

    Panel Discussant: Sandeep Basavarajaiah, MD

    Panel Discussant: Donald E. Cutlip, MD, FACC – Beth Israel Deaconess Medical Center

    Panel Discussant: Jean-Francois Tanguay, MD – Montreal Heart Institute/ Univeristy of Montreal

  • 10:15 AM – 10:23 AM ET
    The Physiological Performance of DCB | QFR After DCB PCI and During Angiographic Follow-Up

    Speaker: Bernardo Cortese, MD, FESC, FSCAI – Fondazione Ricerca e Innovazione Cardiovascolare

  • 10:15 AM – 11:10 AM ET
    PARADE OF DCB INDICATIONS

    Moderator: Florim Cuculi, MD – Heart Center Lucerne

    Moderator: Manish Doshi, PhD – Concept Medical

    Moderator: Azeem Latib, MD – Montefiore Medical Center

    Moderator: Semih Oktay, PhD – Cardiomed Device Consultants

  • 10:23 AM – 10:31 AM ET
    Where Does DCB Fit in the Bifurcation Algorithm?

    Speaker: Tuomas Rissanen, MD, PhD – North Karelia Central Hospital

  • 10:31 AM – 10:39 AM ET
    Hybrid Approach of DES and DCB: Leave Nothing Behind?

    Speaker: Antonio Colombo, MD – Humanitas IRCCS

  • 10:39 AM – 10:47 AM ET
    Challenges of DCB and BRS Below-the-Knee

    Speaker: Marianne Brodmann, MD – Medical University Graz

  • 10:47 AM – 10:55 AM ET
    Regulatory Consideration for Drug-Coated Balloons

    Speaker: Tara A. Ryan, MD, MS, MBA – FDA

  • 10:55 AM – 11:10 AM ET
    Panel Discussion: Will DCB Play a Role for Coronary Application in the US?

    Panel Moderator: Florim Cuculi, MD – Heart Center Lucerne

    Panel Moderator: Azeem Latib, MD – Montefiore Medical Center

    Panel Moderator: Semih Oktay, PhD – Cardiomed Device Consultants

    Panel Discussant: Dominic Allocco, MD, MS – Boston Scientific

    Panel Discussant: Antonio Colombo, MD – Humanitas IRCCS

    Panel Discussant: Bernardo Cortese, MD, FESC, FSCAI – Fondazione Ricerca e Innovazione Cardiovascolare

    Panel Discussant: Florim Cuculi, MD – Heart Center Lucerne

    Panel Discussant: Manish Doshi, PhD – Concept Medical

    Panel Discussant: Jeffrey B. Jump, MSc – MedAlliance

    Panel Discussant: Richard J. Rapoza, PhD – Abbott Vascular

    Panel Discussant: Tara A. Ryan, MD, MS, MBA – FDA

    Panel Discussant: Jean-Francois Tanguay, MD – Montreal Heart Institute/ Univeristy of Montreal

  • 11:10 AM – 11:18 AM ET
    Bioresorbable Scaffolds for BTK Intervention – LIFE-BTK Trial

    Speaker: Sahil A. Parikh, MD, FSCAI – Columbia University Vagelos College of Physicians and Surgeons

  • 11:10 AM – 12:15 PM ET
    BRS BIODEGRADABE POLYMERS BIOADAPTORS | IS THERE A FUTURE FOR THE TECHNOLOGY?

    Moderator: Alexandre A. Abizaid, MD, PhD – Incor

    Moderator: Michael H. Joner, MD – Deutsches Herzzentrum Muenchen

    Moderator: Yoshinobu Onuma, MD, PhD – University of Galway

  • 11:18 AM – 11:26 AM ET
    Extrapolation of LIFE-BTK in Real-World Practice

    Speaker: Richard J. Rapoza, PhD – Abbott Vascular

  • 11:26 AM – 11:34 AM ET
    DynamX Bioadaptor: The Next Major Advance to Restore Vessel Function?

    Speaker: Dean J. Kereiakes, MD, FACC, MSCAI – The Christ Hospital Health Network

  • 11:34 AM – 11:42 AM ET
    Update on DynamX Bioadaptor Trial Results: INFINITY-SWEDEHEART

    Speaker: David Erlinge, MD, PhD – Lund University

  • 11:42 AM – 11:50 AM ET
    DREAMS 3G Including New Vasomotion Data

    Speaker: Michael Haude, MD, PhD – Rheinland Klinikum Neuss GmbH

  • 11:50 AM – 11:58 AM ET
    Long-Term Clinical Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: Final Five-Year Results of the AIDA Randomized Clinical Trial

    Speaker: Ruben Yannick Gerold Tijssen, MD, PhD – St. Antonius Ziekenhuis Nieuwegein / Academic Medical Center Amsterdam

  • 11:58 AM – 12:15 PM ET
    Discussion: Is There a Role/Need for Bioresorbable and/or Bioadaptor Platforms?

    Panel Moderator: Alexandre A. Abizaid, MD, PhD – Incor

    Panel Moderator: Michael H. Joner, MD – Deutsches Herzzentrum Muenchen

    Panel Moderator: Yoshinobu Onuma, MD, PhD – University of Galway

    Panel Discussant: Sandeep Basavarajaiah, MD

    Panel Discussant: David Erlinge, MD, PhD – Lund University

    Panel Discussant: Michael Haude, MD, PhD – Rheinland Klinikum Neuss GmbH

    Panel Discussant: Semih Oktay, PhD – Cardiomed Device Consultants

    Panel Discussant: Sahil A. Parikh, MD, FSCAI – Columbia University Vagelos College of Physicians and Surgeons

    Panel Discussant: Richard J. Rapoza, PhD – Abbott Vascular

    Panel Discussant: Pieter C. Smits, PhD, FESC – CERC (Cardiovascular European Research Center)

    Panel Discussant: Ruben Yannick Gerold Tijssen, MD, PhD – St. Antonius Ziekenhuis Nieuwegein / Academic Medical Center Amsterdam

  • 12:15 PM ET
    Adjourn